Avenanthramides Market Size To Reach $295.0 Million By 2033

Avenanthramides Market Growth & Trends

The global avenanthramides market is anticipated to reach USD 295.0 Million by 2033 and is anticipated to expand at a CAGR of 9.3% from 2025 to 2033, according to a new report by Grand View Research, Inc. The Avenanthramides market is expanding rapidly as demand for natural, plant-derived bioactive ingredients rises in personal care, cosmetics, and nutraceutical applications. Consumers increasingly seek compounds with proven anti-inflammatory and antioxidant benefits, driving formulators to incorporate avenanthramides into skincare, anti-aging, and functional health products. The growing preference for natural alternatives over synthetic ingredients strengthens the market’s commercial potential.

The market is growing due to rising consumer awareness of safe, natural compounds that support skin health and overall wellness. Scientific research confirming the efficacy of avenanthramides in reducing inflammation, oxidative stress, and skin irritation enhances trust and adoption. The expansion of premium personal care and nutraceutical products creates demand for multifunctional ingredients. Manufacturing improvements and efficient extraction techniques increase ingredient availability and purity, making formulations more effective. Clean-label trends encourage the inclusion of recognizable natural compounds, while regulatory approval of plant-based actives promotes confidence among manufacturers and end-users, supporting sustained market expansion.

The Personal Care & Cosmetics segment holds the largest share and is driving market growth. Avenanthramides are highly effective in addressing sensitive skin, redness, and aging concerns, making them ideal for skincare formulations. Consumer preference for natural, multifunctional, and premium products fuels adoption in this segment. Stability and compatibility of avenanthramides in creams, serums, and lotions make them attractive for formulators. Rising awareness of antioxidant and anti-inflammatory benefits reinforces their inclusion in cosmetic products. Demand for soothing and protective formulations ensures that personal care and cosmetics remain the dominant segment while continuing to grow steadily.

Asia Pacific leads the market, supported by strong consumption of skincare and cosmetic products in China, Japan, and South Korea. Urbanization, increasing incomes, and growing awareness of natural ingredients drive market penetration. North America is growing rapidly due to early adoption of plant-based bioactives, strong research capabilities, and consumer preference for scientifically validated ingredients. Europe maintains steady growth as regulations favor safe and natural compounds. Latin America and the Middle East & Africa are expanding gradually, fueled by rising incomes, urban lifestyles, and increasing interest in multifunctional natural ingredients.

The market outlook remains promising with sustained growth across personal care, cosmetics, and pharmaceutical applications. Investment in research, formulation innovation, and scalable extraction methods supports wider adoption. Sustainability and natural ingredient trends align with consumer expectations. Avenanthramides are increasingly integrated into multifunctional and premium products, providing opportunities for market expansion in both established and emerging regions.

 Request a free sample copy or view report summary: Avenanthramides Market Report

Avenanthramides Market Report Highlights

• The demand for avenanthramides is rising due to increasing consumer preference for natural, plant-based ingredients with anti-inflammatory and antioxidant properties. Consumers are moving away from synthetic compounds, seeking safer and multifunctional options in skincare, anti-aging, and nutraceutical products. Scientific studies demonstrating efficacy and safety have strengthened confidence among manufacturers and end-users, encouraging wider adoption in personal care, cosmetic, and pharmaceutical formulations.

• The market is segmented into natural and synthetic avenanthramides. The synthetic segment currently holds the largest revenue share due to its consistent quality, scalability, and availability, making it suitable for high-volume applications. The natural segment is growing rapidly as consumers seek sustainable, plant-derived alternatives that align with clean-label trends. Natural avenanthramides are increasingly incorporated into premium skincare, wellness, and functional health products due to their perceived safety, bioactivity, and environmental benefits.

• Asia Pacific is the fastest-growing region, driven by strong consumption of personal care and cosmetic products in countries such as China, Japan, and South Korea. Increasing disposable incomes, urbanization, and awareness of natural, multifunctional ingredients support regional growth. Large populations and expanding manufacturing infrastructure enhance product availability, while the preference for premium and scientifically validated ingredients accelerates adoption, positioning Asia Pacific as a leading contributor to global market expansion.

• In March 2025, COSCIENS Biopharma announced successful Phase 1 trials of its oat-derived avenanthramide, showing excellent safety. The company will advance to Phase 2a efficacy studies in patients with mild to moderate inflammation at the Montreal Heart Institute.

Avenanthramides Market Segmentation

For this report, Grand View Research has segmented the global avenanthramides market on the basis of product, end-use, and region:

Avenanthramides Product Outlook (Revenue, USD Million; Volume, Kilotons; 2018 - 2033)

• Natural

• Synthetic

Avenanthramides End-use Outlook (Revenue, USD Million; Volume, Kilotons; 2018 - 2033)

• Personal Care & Cosmetics

• Pharmaceuticals

• Animal Health

• Other End-use

Avenanthramides Regional Outlook (Revenue, USD Million; Volume, Kilotons; 2018 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Latin America

• • Brazil

  • Argentina

• Europe

  • Germany

  • UK

  • Italy

  • Spain

  • France

• Asia Pacific

  • China

  • Japan

  • South Korea

• Middle East & Africa

  • Saudi Arabia

  • South Africa

List of Key Players in the Avenanthramides Market

• Ceapro Inc.

• Cosciens Biopharma Inc.

• Chemicea Pharma

• Symrise AG

• Chen Lan gBio

• Henan Steeda Industrial Co., Ltd.

• BioCrick